Press Releases

NORTH CHICAGO, Ill., Nov. 27, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of November 25, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,862,394 shares of common stock with a par value of $0.0

Revenue Fluctuated Amidst the Challenging Market ConditionsSignificant Increase in Revenue Noted at Beijing Sunbow Obstetrics & Gynecology Hospital HONG KONG, Nov. 27, 2019 /PRNewswire/ --

HUDDINGE, Sweden, Nov. 27, 2019 /PRNewswire/ -- July - SeptemberFinancial summaryNet turnover amounted to SEK 1.7 (3.0) million.The loss before interest, tax, depreciation and amortization (EBITDA) totaled SEK -22.0 (-66,9) million. Basic and diluted earnings per shar

CHICAGO, Nov. 27, 2019 /PRNewswire/ -- Little is known about the origins of manikins—small anatomical sculptures thought to be used by doctors four centuries ago—but now advanced imaging techniques have offered a revealing glimpse inside these captivating ivory dolls. Researchers using micro-CT successfully identified the material composition and components o

CHICAGO, Nov. 27, 2019 /PRNewswire/ -- Researchers are trying to identify injury patterns and predict future outcomes for victims of gun violence who are seen in the emergency room and later readmitted to the hospital, according to research being presented next week at the annual meeting of the Radiological Society of North America (RSNA)

STOCKHOLM, Nov. 27, 2019 /PRNewswire/ -- Excessive working hours, forced labor and discrimination are some of the problems that risk workers' health in the IT industry. Achieving a more socially sustainable industry requires long term investments, follow-up and clear consequences that encourage action.

STOCKHOLM, Nov. 27, 2019 /PRNewswire/ --  "Something that really differentiates cobitolimod from its competitors is the superior safety profile. Both the approved drugs and those currently being tested in phase III are associated with serious side effects. With an outstanding combination of efficacy and safety, cobitolimod is set to take a leading position within

SUZHOU, China, Nov. 26, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced with Beijing Hanmi Pharmaceutical Co., Ltd. (a subsidiary o

VAUGHAN, ON, Nov. 26, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today announced that the Toronto Stock Exchange ("TSX") has advised the Company that it intends to review CannTrust's eligibility for continued listing of the Company's common shares on the TSX, pursuant to Part VII of the TSX Company Manual.

LAKE FOREST, Ill., Nov. 26, 2019 /PRNewswire/ -- OMRON Healthcare, Inc., the global leader in personal heart health and wellness technology, is recognized in TIME Magazine in the prestigious Best Inventions 2019 list for HeartGuide™, the first wearable blood pressure monitor.